Premier's 15min chart triggers MACD Death Cross, KDJ Death Cross.

The 15-minute chart for Premier has recently triggered a MACD Death Cross and a KDJ Death Cross, which occurred on August 27, 2025 at 11:30. This technical indicator suggests that the stock price has the potential to continue declining, as the momentum of the stock price has shifted towards the downside and may further decrease.

Premier Health of America Inc. (PHAM) has recently encountered a series of technical indicators suggesting a bearish trend, while also reporting significant financial challenges in its Q3 results. On August 27, 2025, at 11:30, the 15-minute chart for Premier triggered a MACD Death Cross and a KDJ Death Cross, signaling a potential downward trajectory in the stock price [1].

The technical indicators, which include the MACD Death Cross, KDJ Death Cross, and Bearish Marubozu, suggest a weakening momentum and a potential decrease in value. Sellers currently dominate the market, indicating a bearish momentum that is likely to persist [1].

Premier Health of America Inc. reported its Q3 financial results, revealing a significant decline in revenue and a substantial net loss. The company's adjusted EBITDA also fell significantly compared to the previous year. Key drivers of this performance include volume decline, the impact of Quebec's Bill 10, and contract cancellations due to wildfires in Ontario [1].

Financial Performance:
- Revenue: PHAM's Q3 revenue fell to CAD 21.9 million, down from CAD 36.7 million in 2024.
- Net Loss: The net loss for Q3 was CAD 3.5 million, an improvement from CAD 8.4 million in the same period last year.
- Adjusted EBITDA: Adjusted EBITDA for Q3 was CAD 22,000, a significant decline from CAD 367,000 in 2024.

Outlook:
Premier Health has committed to adapting its cost structure in British Columbia and managing its debt. The company aims to address the challenges it faces in Quebec and Ontario, with a focus on cost reduction and debt management [1].

The company's stock has faced a challenging period, with the one available analyst rating on the shares being "hold," while the average consensus recommendation for the software peer group is "buy." The median 12-month price target for PHAM is CAD 0.20, about 77.5% above its August 20 closing price of CAD 0.05 [1].

In contrast, Premier Inc. (PINC) reported better-than-expected Q4 earnings, beating analyst consensus estimates. The company sees FY2026 adjusted EPS of $1.33-$1.43 and sales of $940.000 million-$1.000 billion. Shares fell 3.3% to $25.35 after the earnings report [2].

References:
[1] https://www.ainvest.com/news/premier-15min-chart-macd-death-cross-kdj-death-cross-bearish-marubozu-2508/
[2] https://www.ainvest.com/news/premier-posts-12-revenue-drop-q4-exceeds-estimates-2508/